TrialCancer immunology, immunotherapy : CII2008
Impact of IFNalpha2b upon pSTAT3 and the MEK/ERK MAPK pathway in melanoma.
Wenjun Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
TrialCancer immunology, immunotherapy : CII2008
Wenjun Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.